{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:26:12Z","timestamp":1792070772507,"version":"4.4.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,23]]},"DOI":"10.7759\/cureus.76267","type":"journal-article","created":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T13:52:16Z","timestamp":1734961936000},"source":"Crossref","is-referenced-by-count":10,"title":["Improvement of Recalcitrant Folliculitis Decalvans With Tirzepatide: A Case Report"],"prefix":"10.7759","author":[{"given":"Kali","family":"Morrissette","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Pavlis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-023-09825-1","article-title":"Beyond glycemia: comparing tirzepatide to GLP-1 analogues","volume":"24","author":"Andraos J","year":"2023","unstructured":"Andraos J, Muhar H, Smith SR. Beyond glycemia: comparing tirzepatide to GLP-1 analogues. Rev Endocr Metab Disord. 2023, 24:1089-101. 10.1007\/s11154-023-09825-1","journal-title":"Rev Endocr Metab Disord"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1159\/000529301","article-title":"Folliculitis decalvans has a heterogeneous microbiological signature and impaired immunological response","volume":"239","author":"Moreno-Arrones OM","year":"2023","unstructured":"Moreno-Arrones OM, Garcia-Hoz C, Del Campo R, et al.. Folliculitis decalvans has a heterogeneous microbiological signature and impaired immunological response. Dermatology. 2023, 239:454-61. 10.1159\/000529301","journal-title":"Dermatology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2924","article-title":"Inflammasome activation characterizes lesional skin of folliculitis decalvans","volume":"98","author":"Eyraud A","year":"2018","unstructured":"Eyraud A, Milpied B, Thiolat D, Darrigade AS, Boniface K, Ta\u00efeb A, Seneschal J. Inflammasome activation characterizes lesional skin of folliculitis decalvans. Acta Derm Venereol. 2018, 98:570-5. 10.2340\/00015555-2924","journal-title":"Acta Derm Venereol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2012.04591","article-title":"First evidence of bacterial biofilms in the anaerobe part of scalp hair follicles: a pilot comparative study in folliculitis decalvans","volume":"27","author":"Matard B","year":"2013","unstructured":"Matard B, Meylheuc T, Briandet R, Casin I, Assouly P, Cavelier-balloy B, Reygagne P. First evidence of bacterial biofilms in the anaerobe part of scalp hair follicles: a pilot comparative study in folliculitis decalvans. J Eur Acad Dermatol Venereol. 2013, 27:853-60. 10.1111\/j.1468-3083.2012.04591","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/2042018814543483","article-title":"Effect of glucagon-like peptide-1 receptor agonists in patients with psoriasis","volume":"5","author":"Al-Badri MR","year":"2014","unstructured":"Al-Badri MR, Azar ST. Effect of glucagon-like peptide-1 receptor agonists in patients with psoriasis. Ther Adv Endocrinol Metab. 2014, 5:34-8. 10.1177\/2042018814543483","journal-title":"Ther Adv Endocrinol Metab"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2024.03.021","article-title":"Dermatologic findings associated with semaglutide use: a scoping review","volume":"91","author":"Tran MM","year":"2024","unstructured":"Tran MM, Mirza FN, Lee AC, Goldbach HS, Libby TJ, Wisco OJ. Dermatologic findings associated with semaglutide use: a scoping review. J Am Acad Dermatol. 2024, 91:166-8. 10.1016\/j.jaad.2024.03.021","journal-title":"J Am Acad Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-011-2232-3","article-title":"Glucagon-like peptide-1 (GLP-1) and the regulation of human invariant natural killer T cells: lessons from obesity, diabetes and psoriasis","volume":"54","author":"Hogan AE","year":"2011","unstructured":"Hogan AE, Tobin AM, Ahern T, et al.. Glucagon-like peptide-1 (GLP-1) and the regulation of human invariant natural killer T cells: lessons from obesity, diabetes and psoriasis. Diabetologia. 2011, 54:2745-54. 10.1007\/s00125-011-2232-3","journal-title":"Diabetologia"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1148209","article-title":"Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent","volume":"14","author":"Mehdi SF","year":"2023","unstructured":"Mehdi SF, Pusapati S, Anwar MS, et al.. Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent. Front Immunol. 2023, 14:1148209. 10.3389\/fimmu.2023.1148209","journal-title":"Front Immunol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.17246","article-title":"GLP-1 agonists and hair loss: a call for further investigation","volume":"63","author":"Desai DD","year":"2024","unstructured":"Desai DD, Sikora M, Nohria A, Bordone L, Caplan AS, Shapiro J, Lo Sicco KI. GLP-1 agonists and hair loss: a call for further investigation. Int J Dermatol. 2024, 63:1128-30. 10.1111\/ijd.17246","journal-title":"Int J Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2024.06.001","article-title":"Treatment of insulin resistance with tirzepatide leading to improvement of hair loss","volume":"50","author":"Gordon ER","year":"2024","unstructured":"Gordon ER, Musleh S, Bordone LA. Treatment of insulin resistance with tirzepatide leading to improvement of hair loss. JAAD Case Rep. 2024, 50:123-5. 10.1016\/j.jdcr.2024.06.001","journal-title":"JAAD Case Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/325695-improvement-of-recalcitrant-folliculitis-decalvans-with-tirzepatide-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T13:52:17Z","timestamp":1734961937000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/325695-improvement-of-recalcitrant-folliculitis-decalvans-with-tirzepatide-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,23]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.76267","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,23]]}}}